Brookside Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Interview with Jay Venkatesan, M.D., the President, Chief Executive Officer, and Chairman of Angion Biomedica Corp. (ANGN).

Posted on 7440 Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing. This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The financing was led by existing shareholder The Baupost Group, with participation from existing investors including LifeForce Capital and new investors including Schooner Capit...

Press release content from Business Wire. The AP news staff was not involved in its creation. Wren Therapeutics Announces Financing of £12.4 Million (c. $17.0 Million) January 25, 2021 GMT CAMBRIDGE, United Kingdom--(BUSINESS WIRE)--Jan 25, 2021-- Wren Therapeutics Ltd., (“Wren”), a biopharmaceutical company pioneering a unique network kinetics approach to drug discovery for protein misfolding diseases, today announced the closing of a £12.4 million (c. $17.0 million) financing. This financing brings the total capital raised to date to approximately £33 million (c. $45 million). The fi...

Reported extensively on bain's activities during romney's tenure. he's also the author of "showdown." david, thank you for your time tonight. >> thanks for having me. >> now, you've done a lot of digging in romney and bain. you looked at how the company was deeply involved in outsourcing. tell us what you found. >> thanks for asking. there are two key things here. bain capital which would buy up companies and help manage them. and a few weeks ago the washington post did a good piece by tom hamburger knowing that six of those companies were engaged in outsourcing. and the romney campaign said h...